Onconetix, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Onconetix, Inc. (ONCO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 709.77 thousand shares for the 0-month period ending 2023-10-04, per its 10-K filed 2024-04-11.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2024-04-11
- Onconetix, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 100.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|
| 2023-10-04 | 709.77K shares 10-K · filed 2024-04-11 | ||
| 2023-06-30 | 512.94K shares 10-Q · filed 2023-10-20 | ||
| 2022-12-31 | 100.00K shares 10-K · filed 2024-04-11 | ||
| 2022-06-30 | 714.54K shares 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |